Acciones Perrigo Company PLC TEL AVIV STOCK EXCHANGE
Acciones
IE00BGH1M568
Farmacéuticos
Ventas 2024 * | 4658,92 M 1.726000 M 4329,49 M | Ventas 2025 * | 4862,95 M 1.802000 M 4519,09 M | Capitalización | 4443,57 M 1.646000 M 4129,36 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | -51 M -18,9 mil M -47,39 M | Resultado Neto 2025 * | 105 M 38,9 mil M 97,58 M | VE / Ventas 2024 * | 1,64 x |
Deuda neta 2024 * | 3193,5 M 1.183000 M 2967,69 M | Deuda neta 2025 * | 3056 M 1.132000 M 2839,91 M | VE / Ventas 2025 * | 1,54 x |
P/E ratio 2024 * |
-44,9
x | P/E ratio 2025 * |
121
x | Empleados | - |
Rendimiento 2024 * |
3,35 % | Rendimiento 2025 * |
3,57 % | Flotante | 99,69 % |
Último transcript sobre Perrigo Company PLC
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 55 | 30/06/23 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 16/05/22 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/15 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 15/12/20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 06/02/17 |
Bradley Alford
BRD | Director/Board Member | 67 | 06/02/17 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,08 % | 662 mil M | |
+21,85 % | 546 mil M | |
-4,77 % | 359 mil M | |
+16,97 % | 323 mil M | |
+5,69 % | 290 mil M | |
+13,68 % | 234 mil M | |
+3,65 % | 198 mil M | |
-11,12 % | 194 mil M | |
+8,08 % | 167 mil M |